Latest News and Press Releases

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products (Apr 23rd - Apr 24th, 2026)" training has been added...

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "The Common Technical Document (May 14th - May 15th, 2026)" training has been added to ResearchAndMarkets.com's offering.This interactive two-day...

PannTheraPi annonce des avancées majeures dans son développement clinique et stratégique  Le dépôt du dossier réglementaire pour l’initiation de l’essai clinique de Phase 2a évaluant son candidat...

PannTheraPi files Phase 2a trial for epilepsy drug PTI5803, secures EU patent, and appoints Sophie Binay as GM & CSO.

WALTHAM, Mass., April 13, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody...

BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Variations to Marketing Authorisations (June 2nd - June 3rd, 2026)" training has been added to ResearchAndMarkets.com's offering. This course...

- Veteran biopharmaceutical and oncology leader brings more than three decades of experience across clinical development, regulatory, and operational execution SOUTH SAN FRANCISCO, Calif., April 13,...

Veld Pharmaceuticals, announced a collaboration with Chiesi Farmaceutici S.p.A in Africa for Rare Disease Therapies

Israel Tech Week 2026 moves forward in Miami, connecting Israeli startups, investors and global partners amid ongoing conflict in Israel.